Chronic glucocorticoid excess and impaired osmoregulation of vasopressin release in dogs with hepatic encephalopathy

Epstein, 1988, Renal sodium handling in liver disease, 3 Levy, 1977, Sodium retention in dogs with cirrhosis and ascites: Efferent mechanisms, Am J Physiol, 233, F586 Salerno, 1988, Renal response to atrial natriuretic peptide in patients with advanced liver cirrhosis, Hepatology, 8, 21, 10.1002/hep.1840080106 Trevesani, 1989, Circadian variation in renal sodium and potassium handling in cirrhosis, Gastroenterology, 96, 1187, 10.1016/0016-5085(89)91640-5 Ohno, 1993, Sodium retention and hepatic function following partial portal vein ligation in the rat, J Hepatol, 18, 235, 10.1016/S0168-8278(05)80251-X Johnson, 1991, The effect of liver disease on the endocrine system, 1214 Epstein, 1988, Renin-angiotensin system in liver disease, 331 Bernardi, 1983, Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation, Gut, 24, 761, 10.1136/gut.24.8.761 Bernardi, 1985, Importance of plasma aldosterone concentration on natriuretic effect of spironolactone in patients with liver cirrhosis and ascites, Digestion, 31, 189, 10.1159/000199198 Angeli, 1992, Variability of atrial natriuretic peptide levels in ascitic cirrhotics: pathophysiological and clinical implications, Hepatology, 16, 1389, 10.1002/hep.1840160614 Legault, 1993, Assessment of atrial natriuretic peptide resistance in cirrhosis with head-out water immersion and atrial natriuretic peptide infusion, Can J Physiol Pharmacol, 71, 157, 10.1139/y93-022 Jespersen, 1988, Disturbed relationship between urinary prostaglandin E2 excretion, plasma arginine vasopressin and renal water excretion after oral water loading in early hepatic cirrhosis, Eur J Clin Invest, 18, 202, 10.1111/j.1365-2362.1988.tb02414.x Castellano, 1991, Antidiuretic hormone and renal function after water loading in patients with cirrhosis of the liver, Scand J Gastroenterol, 26, 49, 10.3109/00365529108996483 Solis-Herruzo, 1992, Metabolic clearance of arginine vasopressin in patients with cirrhosis, Hepatology, 16, 974, 10.1002/hep.1840160420 Kim, 1993, Vasopressin gene expression in rats with experimental cirrhosis, Hepatology, 17, 134, 10.1002/hep.1840170124 Johnson, 1954, Bioassay of adrenal cortical steroids on the basis of electrolyte excretion by rats. Effects of 11-desoxy and 11-oxy steroids, Endocrinology, 54, 196, 10.1210/endo-54-2-196 Vagnucci, 1974, Intradiem changes of plasma aldosterone, cortisol, corticosterone, and growth hormone in sodium restriction, J Clin Endocrinol Metab, 38, 761, 10.1210/jcem-38-5-761 Kawai, 1985, Differences in metabolic properties among cortisol, prednisolone, and dexamethasone in liver and renal diseases: accelerated metabolism of dexamethasone in renal failure, J Clin Endocrinol Metab, 60, 848, 10.1210/jcem-60-5-848 Rothuizen, 1987, The pituitary-adrenocortical system in canine hepato-encephalopathy, Front Horm Res, 17, 28, 10.1159/000414816 Biewenga, 1991, Osmoregulation of systemic vasopressin release during long-term glucocorticoid excess: A study in dogs with hyperadrenocorticism, Acta Endocrinol, 124, 583, 10.1530/acta.0.1240583 Rees, 1977, Alcohol-induced pseudo-Cushing's syndrome, Lancet, 1, 726, 10.1016/S0140-6736(77)92169-9 Majumdar, 1988, The dexamethasone suppression test in chronic alcoholics with and without depression and its relationship to their hepatic status, Drug Alcohol Depend, 21, 231, 10.1016/0376-8716(88)90074-9 Smals, 1977, Alcohol-induced pseudo-Cushing's syndrome, Lancet, 1, 1369, 10.1016/S0140-6736(77)92586-7 Wand, 1991, Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics, J Clin Endocrinol Metab, 72, 1290, 10.1210/jcem-72-6-1290 Burra, 1992, Severity of alcoholic liver disease and markers of thyroid and steroid status, Postgrad Med J, 68, 804, 10.1136/pgmj.68.804.804 Kley, 1975, Steroid hormones and their binding in plasma in male patients with fatty liver, chronic hepatitis and liver cirrhosis, Acta Endocrinol, 79, 275, 10.1530/acta.0.0790275 Orbach, 1989, Increased serum cortisol binding in chronic active hepatitis, Am J Med, 86, 39, 10.1016/0002-9343(89)90227-1 Demelia, 1991, Hypothalamo-pituitary-adrenal function in liver cirrhosis of viral etiology, Ann Ital Med Int, 6, 203 McCann, 1975, Cortisol metabolism in chronic liver disease, J Clin Endocrinol Metab, 40, 1038, 10.1210/jcem-40-6-1038 Rothuizen, 1982, Rectal ammonia tolerance test in the evaluation of portal circulation in dogs with liver disease, Res Vet Sci, 33, 22, 10.1016/S0034-5288(18)32353-1 Rijnberk, 1988, Assessment of two tests for the diagnosis of canine hyperadrenocorticism, Vet Rec, 122, 178, 10.1136/vr.122.8.178 Biewenga, 1987, Vasopressin in polyuric syndromes in the dog, Front Horm Res, 17, 139, 10.1159/000414827 Hellebrekers, 1987, Effect of methadone on plasma arginine vasopressin level and urine production in conscious dogs, Eur J Pharmacol, 136, 279, 10.1016/0014-2999(87)90299-8 Jarrett, 1985, A new transmissible agent causing acute hepatitis, chronic hepatitis and cirrhosis in the dog, Vet Rec, 116, 629, 10.1136/vr.116.24.629 Van den Ingh, 1982, Hepatoportal fibrosis in three young dogs, Vet Rec, 110, 575, 10.1136/vr.110.25.575 Suter, 1975, Portal vein anomalies in the dog: their angiographic diagnosis, Am J Vet Radiol, 16, 84, 10.1111/j.1740-8261.1975.tb01324.x Mendel, 1989, Uptake of cortisol by the perfused rat liver: Validity of the free hormone hypothesis applied to cortisol, Endocrinology, 124, 468, 10.1210/endo-124-1-468 Mendel, 1989, The free hormone hypothesis: a physiologically based mathematical model, Endocrinol Rev, 10, 232, 10.1210/edrv-10-3-232 Stewart, 1993, 11β-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and nonalcoholic chronic liver disease, J Clin Endocrinol Metab, 76, 748, 10.1210/jc.76.3.748 De Kloet, 1991, Brain corticosteroid receptor balance and homeostatic control, Front Neuroendocrinol, 12, 95 James, 1976, Alterations in brain octopamine and brain tyrosine following portacaval anastomosis in rats, J Neurochem, 270, 223, 10.1111/j.1471-4159.1976.tb01568.x Fischer, 1979, False neurotransmitters and hepatic failure, Lancet, 2, 75, 10.1016/S0140-6736(79)90064-3 Appelgren, 1991, Mechanism of drinking-induced inhibition of vasopressin secretion in dehydrated dogs, Am J Physiol, 261, R1226 Quillen, 1983, Influence of volume changes on osmolality-vasopressin relationships in conscious dogs, Am J Physiol, 244, H73 Lutz-Bucher, 1986, Central nervous system control of pituitary vasopressin receptors: Evidence for involvement of multiple factors, Neuroendocrinology, 43, 618, 10.1159/000124590 Robinson, 1983, Quantitation of changes in the content of neurohypophysial peptides in hypothalamic nuclei after adrenalectomy, Neuroendocrinology, 36, 347, 10.1159/000123479 Raff, 1989, Feedback control of vasopressin and corticotrophin secretion in conscious dogs: Effect of hypertonic saline, J Endocrinol, 122, 41, 10.1677/joe.0.1220041 Basset, 1987, Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAa-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure, Gastroenterology, 93, 1069, 10.1016/0016-5085(87)90571-3 Roberts, 1984, The gamma-aminobutyric acid (GABA) system and hepatic encephalopathy, Hepatology, 4, 342, 10.1002/hep.1840040228 Baraldi, 1982, Experimental hepatic encephalopathy: changes in the binding of gamma amino butyric acid, Science, 216, 427, 10.1126/science.6280279 Maddison, 1987, Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy, Hepatology, 7, 621, 10.1002/hep.1840070402 Mullen, 1987, CSF of patients with hepatic encephalopathy (HE) contains significant benzodiazepine (BZ) binding activity. Correlations with postmortem cortical BZ binding studies, Hepatology, 7, 1103 Mullen, 1989, Detection and characterization of endogenous benzodiazepine activity in both animal models and humans with hepatic encephalopathy, 287 Bakti, 1987, Mechanism of the excessive sedative response of cirrhotics to benzodiazepines: model experiments with triazolan, Hepatology, 7, 629, 10.1002/hep.1840070403 Sladek, 1987, Gamma-aminobutyric acid antagonists stimulate vasopressin release from organ-cultured hypothalamo-neurohypophyseal explants, Endocrinolgy, 120, 1576, 10.1210/endo-120-4-1576 Chiodera, 1989, Effects of the GABAergic agent sodium valproate on the arginine vasopressin responses to hypertonic stimulation and upright posture in man, Clin Endocrinol, 30, 389, 10.1111/j.1365-2265.1989.tb00437.x Voigt, 1985, Immunochemical studies on biosynthesis of rat plasma angiotensinogen and its regulation by cortisol, Biochim Biophys Acta, 842, 100, 10.1016/0304-4165(85)90299-5 Perschel, 1991, Bile acids and their amidates inhibit 11 beta-hydroxysteroid dehydrogenase obtained from rat kidney, Pflugers Arch, 418, 538, 10.1007/BF00370568 Reul, 1987, Differential response of type 1 and type 2 corticosteroid receptors to changes in plasma steroid level and circadian rhythmicity, Neuroendocrinology, 45, 407, 10.1159/000124766 Reul, 1990, Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary, Endocrinology, 127, 907, 10.1210/endo-127-2-907 Funder, 1988, Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated, Science, 242, 583, 10.1126/science.2845584 Mercer, 1992, Localization of an 11-β-hydroxysteroid dehydrogenase activity to the distal nephron. Evidence for the existence of two species of dehydrogenase in the rat kidney, Endocrinology, 130, 540, 10.1210/en.130.1.540